A study on Ozempic found that 40% of participants who took the medication experienced no heavy drinking days in the last month, compared to 20% of those taking a placebo. Smoking rates also declined among Ozempic users. Dr. Klara Klein, an assistant professor at the University of North Carolina at Chapel Hill, suggests that semaglutide and similar drugs may help treat alcohol use disorder, with larger studies needed for further understanding.
https://www.upi.com/Health_News/2025/02/12/Ozempic-alcoholism-study/7281739377859/Methylene blue is being researched for its potential to treat various conditions due to its ability to boost oxygen levels in the blood, which may improve mitochondrial function and slow down ageing or prevent cancer. It has been suggested as a possible preventative treatment for dementia, depression, bipolar disorder, and recurrent urinary tract infections (UTIs). Studies have shown promising results, including a significant improvement in symptoms of bipolar disorder and a marked reduction in depressive thoughts. However, experts caution that the majority of studies are too small to be considered significant, and experimenting with methylene blue without medical supervision can lead to serious consequences, such as serotonin syndrome, which can cause confusion, agitation, muscle twitching, seizures, and even unconsciousness.
https://www.dailymail.co.uk/health/article-14384221/cancer-cure-drug-methylene-blue-kennedy-health-fish.htmlKeio University researchers have found that mice exposed to stress exhibit changes in their brain structure similar to those seen in humans with depression and anxiety disorders. The study, conducted at Keio's School of Medicine, used mice with different genetic backgrounds to test the effects of stress on brain development. The results suggest that chronic stress can lead to long-term changes in the brain's reward system, which may contribute to mental health issues.
https://www.japantimes.co.jp/news/2025/02/09/japan/science-health/japan-social-loneliness-study/A recent study has found that hospital and emergency room patients diagnosed with cannabis use disorder are at a significantly higher risk of death, including from suicide. The study, published on Friday, revealed that these patients died at almost three times the rate of those without the disorder over the next five years. Specifically, patients with cannabis use disorder were 10 times as likely to die by suicide compared to the general population.
https://www.smh.com.au/world/north-america/it-is-a-public-health-threat-just-like-alcohol-marijuana-dependence-linked-to-higher-risk-of-death-20250207-p5laee.htmlMindMed has launched its second phase 3 study, Panorama, to assess the efficacy and safety of MM120 ODT, a pharmaceutically optimized form of LSD, for treating Generalized Anxiety Disorder (GAD). The treatment aims to address a significant unmet need in psychiatry by targeting neurotransmitter pathways critical to brain health.
https://markets.businessinsider.com/news/stocks/mind-medicine-mnmd-advances-groundbreaking-lsd-treatment-1034321195A psychiatrist at AIIMS has warned that obesity is linked to mental health risks such as body-image issues, mood swings, anxiety, depression, and self-isolation in individuals. This can lead to emotional eating and make weight management more challenging.
https://www.lokmattimes.com/health/mental-health-at-risk-aiims-psychiatrist-warns-of-obesity-linked-anxiety-and-depression-a505/A study conducted by a team from Harvard University and Massachusetts General Hospital has found a probable link between the intestinal bacteria Morganella morganii and major depressive disorder. The research, published in the Journal of the American Chemical Society, suggests that this type of bacteria may trigger an autoimmune inflammatory response that contributes to depression. Specifically, the scientists discovered that diethanolamine, a chemical found in some detergents, can alter the molecule produced by Morganella morganii in the gut, potentially leading to the onset of depression.
https://www.scmp.com/lifestyle/health-wellness/article/3297392/feeling-low-how-your-gut-health-bacteria-may-trigger-depression-study-says?module=top_story&pgtype=sectionAccording to a new study published in the BMJ Mental Health journal, nearly 50,000 people who participated in a two-year survey reported feeling their happiest in the morning and worst at midnight. The researchers from University College London analyzed data from the COVID-19 Social Study, which found that Mondays and Fridays were happier days than Sundays, while Tuesdays also showed improved moods. The study's findings suggest that time of day is associated with depression, anxiety, wellbeing, and loneliness, and can inform the planning and provision of public health services.
https://www.abc.net.au/news/2025-02-05/happiness-research-mornings-feel-better-than-night-study-finds/104893922Bipolar disorder is a mental health condition characterized by extreme mood swings, ranging from manic episodes of high energy and elation to depressive episodes of somberness and lack of energy. According to the International Bipolar Foundation, individuals with rapid cycling bipolar disorder experience four or more manic, hypomanic, or depressive episodes within a 12-month period, affecting around 10-20% of those with the condition. The cause of bipolar disorder is currently unknown, but research suggests that genetics may play a role, particularly in those with a family history of the condition, which affects approximately 5.7 million US adults aged 18 or older.
https://www.dailymail.co.uk/tvshowbiz/article-14363113/Kanye-West-ex-wife-Kim-Kardashian-doctor-misdiagnosed-bipolar.html